" class="no-js "lang="en-US"> The AI-powered Referral Solution to the UK’s Healthcare Problem - Medtech Alert
Thursday, June 13, 2024

The AI-powered Referral Solution to the UK’s Healthcare Problem

Vantage Health is delighted to announce that it has been acquired by Northgate Public Services (NPS), a leading software and services provider to the public sector in the UK and a wholly owned subsidiary of NEC Corporation. 

NPS has a market leading screening software for diabetes and hearing. It has helped to screen 10 million babies for the Newborn Hearing Screening Program in England and Northern Ireland, tested 500,000 patients with diabetes for retina damage and supports a number of medical registries such as the National Joint Registry (NJR), the largest orthopaedics registry in the world, and the international spinal registry platform, Spine Tango to help clinicians, regulators and industry deliver evidence-based treatments for patients.

Vantage Health (vantage.health), launched its full-service AI-powered referral platform, Rego last December. This is the first eRS compatible solution to be deployed in the NHS, Rego provides automated GP referrals in one efficient system, which reduces the complexity of outpatient pathway guidance and eliminates manual triage processes. As a result, Rego has proven to flatten the waiting list curve in 10 months, improve the chances of early treatment and free up essential healthcare resource – saving the NHS over £200 million each year.*

Rego reviews all referrals against local criteria and pathways and ensures patients are directed to the right care. Widely implemented across the NHS to support thousands of GPs, dentists and opticians, Rego is proven to support effective outpatient transformation in line with the Long-Term Plan and help the NHS as it looks towards recovery from the pandemic.

Tina Whitley, CEO of NPS, says: “Following the pandemic, healthcare is facing a huge challenge to keep up with the surge in demand for outpatient treatment. Effective solutions are needed to be able to manage resources, save money and secure the best outcomes for patients.

“Combining Vantage Health’s ability to transform outpatient care with our expertise of managing successful health screening programmes like hearing and diabetic eye screening, means we can give healthcare providers the tools they need to quickly identify patients who need specialist services and then help them direct the patient to the right support service instantly.”

David Ezra, co-founder of Vantage Health, says: “It’s never been more important for the NHS and healthcare services to have efficient solutions that work. Joining forces with NPS is exciting. It brings together a shared vision for transforming the way healthcare is delivered to offer the best care for patients.”

People In This Post

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more